Hemorphin-7 acetate is a hemoglobin-derived endogenous opioid peptide. It exhibits antinociceptive and antihypertensive effects through dual mechanisms involving opioid receptor activation and angiotensin-converting enzyme (ACE) inhibition, making it a valuable tool for researching neurobiology and cardiovascular physiology in vitro and in vivo.